Praram 9 Hospital Public Company Limited
Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal… Read more
Praram 9 Hospital Public Company Limited (PR9) - Net Assets
Latest net assets as of December 2025: ฿5.88 Billion THB
Based on the latest financial reports, Praram 9 Hospital Public Company Limited (PR9) has net assets worth ฿5.88 Billion THB as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿7.03 Billion) and total liabilities (฿1.15 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿5.88 Billion |
| % of Total Assets | 83.61% |
| Annual Growth Rate | 12.82% |
| 5-Year Change | 37.35% |
| 10-Year Change | 212.39% |
| Growth Volatility | 22.48 |
Praram 9 Hospital Public Company Limited - Net Assets Trend (2014–2025)
This chart illustrates how Praram 9 Hospital Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Praram 9 Hospital Public Company Limited (2014–2025)
The table below shows the annual net assets of Praram 9 Hospital Public Company Limited from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ฿5.88 Billion | +8.04% |
| 2024-12-31 | ฿5.44 Billion | +7.06% |
| 2023-12-31 | ฿5.08 Billion | +7.27% |
| 2022-12-31 | ฿4.74 Billion | +10.70% |
| 2021-12-31 | ฿4.28 Billion | +3.95% |
| 2020-12-31 | ฿4.12 Billion | +1.89% |
| 2019-12-31 | ฿4.04 Billion | +4.28% |
| 2018-12-31 | ฿3.87 Billion | +84.88% |
| 2017-12-31 | ฿2.10 Billion | +11.39% |
| 2016-12-31 | ฿1.88 Billion | +12.67% |
| 2015-12-31 | ฿1.67 Billion | +7.14% |
| 2014-12-31 | ฿1.56 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Praram 9 Hospital Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 246.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿3.07 Billion | 52.33% |
| Other Components | ฿2.80 Billion | 47.67% |
| Total Equity | ฿5.88 Billion | 100.00% |
Praram 9 Hospital Public Company Limited Competitors by Market Cap
The table below lists competitors of Praram 9 Hospital Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SK Chemicals Co Ltd Pref
KO:28513K
|
$222.37 Million |
|
Hefei Hengxin Life Science and Technology Co., Ltd.
SHE:301501
|
$222.41 Million |
|
China Building Material
SHG:603060
|
$222.42 Million |
|
Avantel Limited
NSE:AVANTEL
|
$222.42 Million |
|
Dirui Industrial Co Ltd
SHE:300396
|
$222.26 Million |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
$222.25 Million |
|
CHINA YOUZAN LTD. HD-01
F:YSZ
|
$222.15 Million |
|
Bold Eagle Acquisition Corp. Class A Ordinary Shares
NASDAQ:BEAG
|
$222.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Praram 9 Hospital Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,438,539,594 to 5,875,528,390, a change of 436,988,796 (8.0%).
- Net income of 822,709,359 contributed positively to equity growth.
- Dividend payments of 351,435,963 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿822.71 Million | +14.0% |
| Dividends Paid | ฿351.44 Million | -5.98% |
| Other Changes | ฿-34.28 Million | -0.58% |
| Total Change | ฿- | 8.04% |
Book Value vs Market Value Analysis
This analysis compares Praram 9 Hospital Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.26x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.46x to 2.26x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | ฿2.00 | ฿16.90 | x |
| 2015-12-31 | ฿2.14 | ฿16.90 | x |
| 2016-12-31 | ฿313.48 | ฿16.90 | x |
| 2017-12-31 | ฿349.17 | ฿16.90 | x |
| 2018-12-31 | ฿6.10 | ฿16.90 | x |
| 2019-12-31 | ฿5.14 | ฿16.90 | x |
| 2020-12-31 | ฿5.23 | ฿16.90 | x |
| 2021-12-31 | ฿5.44 | ฿16.90 | x |
| 2022-12-31 | ฿6.02 | ฿16.90 | x |
| 2023-12-31 | ฿6.46 | ฿16.90 | x |
| 2024-12-31 | ฿6.92 | ฿16.90 | x |
| 2025-12-31 | ฿7.47 | ฿16.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Praram 9 Hospital Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.00%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.59%
- • Asset Turnover: 0.75x
- • Equity Multiplier: 1.20x
- Recent ROE (14.00%) is above the historical average (10.02%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 10.41% | 9.13% | 0.98x | 1.17x | ฿6.34 Million |
| 2015 | 11.60% | 9.88% | 0.96x | 1.23x | ฿26.66 Million |
| 2016 | 13.81% | 11.61% | 0.98x | 1.22x | ฿71.73 Million |
| 2017 | 12.52% | 10.83% | 0.85x | 1.36x | ฿52.75 Million |
| 2018 | 4.06% | 5.82% | 0.61x | 1.14x | ฿-230.11 Million |
| 2019 | 7.04% | 9.99% | 0.60x | 1.17x | ฿-119.44 Million |
| 2020 | 4.91% | 7.77% | 0.54x | 1.17x | ฿-209.47 Million |
| 2021 | 5.82% | 8.34% | 0.58x | 1.20x | ฿-178.62 Million |
| 2022 | 11.99% | 13.82% | 0.74x | 1.17x | ฿94.07 Million |
| 2023 | 10.98% | 13.28% | 0.71x | 1.16x | ฿49.89 Million |
| 2024 | 13.10% | 15.37% | 0.72x | 1.18x | ฿168.83 Million |
| 2025 | 14.00% | 15.59% | 0.75x | 1.20x | ฿235.16 Million |
Industry Comparison
This section compares Praram 9 Hospital Public Company Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $2,892,225,945
- Average return on equity (ROE) among peers: 25.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Praram 9 Hospital Public Company Limited (PR9) | ฿5.88 Billion | 10.41% | 0.20x | $222.26 Million |
| Aikchol Hospital Public Company Limited (AHC) | $1.55 Billion | 9.07% | 0.19x | $29.59 Million |
| Bangkok Chain Hospital Public Company Limited (BCH-R) | $6.40 Billion | 17.03% | 0.97x | $429.99 Million |
| Bumrungrad Hospital PCL (BH) | $13.10 Billion | 26.23% | 0.63x | $3.50 Billion |
| Chularat Hospital Public Company Limited (CHG) | $1.12 Billion | 29.84% | 0.38x | $205.50 Million |
| Chiang Mai Ram Medical Business Public Company Limited (CMR) | $5.27 Billion | 8.36% | 0.67x | $21.67 Million |
| Dental Corporation Public Company Limited (D) | $106.33 Million | 39.99% | 1.05x | $9.07 Million |
| Ekachai Medical Care Public Company Limited (EKH) | $953.94 Million | 16.80% | 0.15x | $56.66 Million |
| Genesis Fertility Center Public Company Limited (GFC) | $123.73 Million | 56.28% | 0.53x | $4.77 Million |
| Mukdahan International Hospital Public Company Limited (HANN) | $176.84 Million | 15.70% | 0.95x | $5.00 Million |
| Intermedical Care and Lab Hospital Public Company Limited (IMH) | $123.08 Million | 37.33% | 0.31x | $7.20 Million |